Samsara BioCapital
42 portfolio companies · 7 on the map · $2.9B raised · 5 cities
Portfolio map
7 Samsara BioCapital portfolio companies on the map.
Portfolio companies

Janux Therapeutics
San Diego
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Biotechnology Research$898.9MEst. 2017
Scholar Rock
Cambridge
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Biotechnology$743MEst. 2012
Mineralys Therapeutics
Radnor
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Biotechnology Research$740.5MEst. 2020Hiring fast
LENZ THERAPEUTICS
San Diego
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
Pharmaceutical Manufacturing$217.4M
Spyglass Pharma
Aliso Viejo
Spyglass Pharma provides medicine for ophthalmic diseases.
Pharmaceutical Manufacturing$184.8MEst. 2019
Genalyte
San Diego
Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Biotechnology$154.8MEst. 2007
ElevateBio
Waltham
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
Pharmaceutical ManufacturingSeries DEst. 2017Hiring fast
More portfolio companies
34 more Samsara BioCapital investments we track beyond the map — 42 tracked in total.
Ambrosia BiosciencesBoulder · Series B
Sidewinder TherapeuticsSan Diego · Series B
Seismic TherapeuticWatertown · Series B
CARGO TherapeuticsSan Mateo · Post-IPO Equity
ExcellergyPalo Alto · Series A
EpiBiologicsSan Mateo · Series B
ElektrofiBoston · Series C
NormunityNew Haven · Series B
Enara BioOxford · Series B
Enlaza TherapeuticsLa Jolla · Series A
Dewpoint TherapeuticsBoston · Series C
Upstream BioWaltham · Series B
SynthekineMenlo Park · Series B
Tentarix BiotherapeuticsSan Diego · Series B
AbcuroNewton · Series C
Abata TherapeuticsCambridge · Series A
Alpheus MedicalOakdale · Series B
ACELYRINLos Angeles · Series C
Simcha TherapeuticsNew Haven · Series B
EyebiotechNew York · Series A
Notch TherapeuticsToronto · Series A
Exo TherapeuticsCambridge · Series B
Inventiva PharmaDaix · Post-IPO Equity
Lyra TherapeuticsWatertown · Post-IPO Equity
Rain OncologyNewark · Series B
Kalaris Therapeutics (formerly AlloVir)Houston · Post-IPO Equity
AtrecaSouth San Francisco · Series C
FORMA TherapeuticsWatertown · Series D
vTv TherapeuticsHigh Point · Post-IPO Equity
Chinook TherapeuticsVancouver · Post-IPO Equity
NeurogastrxWoburn · Series B
Hookipa PharmaNew York · Series D
Pieris PharmaceuticalsBoston · Post-IPO Equity
Autobahn LabsPalo Alto · Seed
Portfolio map
7 Samsara BioCapital portfolio companies on the map.